News
17 September 2024
The daily battle against Osteoarthritis: Jocelyne’s Story
Read more5 September 2024
Treatment of patients suffering from Osteoarthritis in China
Read more31 May 2024
KiOmed Pharma celebrates treating its 20,000th patient and looks to the future with optimism
Read more14 November 2023
Refractory Osteoarthritis: insights on the challenges
Read more17 September 2023
KiOmed Pharma and Arsylab Announce Strategic Partnership for the Promotion and Distribution in France of KioMedinevsone, a New Class of Treatment for Refractory Knee Osteoarthritis
Read more8 August 2023
We are always looking for talented people
Read more26 September 2022
KiOmed Pharma and Hansoh Pharma Announce License Agreement for KioMedinevsone in China’s Mainland, Macau and Taiwan
Read more10 May 2022
Using fungi to slow down cellular ageing
Read more7 October 2021
KiOmed Pharma and Sinclair Pharma sign an exclusive partnership based on “KiOmedine®” technology
Read more3 June 2021
KiOmed Pharma and moveUP Partner to Develop and Market a Companion Healthcare Application for Personalised Treatment of Osteoarthritis
Read more24 May 2021
KiOmed Pharma reports promising long-term results in a new European multi centric survey Treatment of Advanced Knee OsteoArthritis
Read more24 June 2020
KiOmed Pharma appoints seasoned industry executives and expands its board of directors
Read more5 May 2020